27 employees
Gemelli is a biotechnology company that specializes in the microbiome, and IBS diagnostics.
2018
$19M
from 4 investors over 4 rounds
Gemelli Biotech raised $19M on June 22, 2022
Investors: Cedars-Sinai, Carolina Angel Network, CerraCap Ventures and Blue Ox Healthcare Partners